These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 35650131)
21. Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection. Lee CC; Lee JC; Chiu CW; Tsai PJ; Ko WC; Hung YP Microbiol Spectr; 2021 Oct; 9(2):e0079921. PubMed ID: 34668727 [TBL] [Abstract][Full Text] [Related]
22. Challenges in the Diagnosis and Management of Recurrent and Severe Clostridioides difficile Infection in Children. Sattler MM; Crews JD J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S27-S33. PubMed ID: 34791399 [TBL] [Abstract][Full Text] [Related]
23. Fecal Microbiota Transplant Decreases Mortality in Patients with Refractory Severe or Fulminant Clostridioides difficile Infection. Cheng YW; Phelps E; Nemes S; Rogers N; Sagi S; Bohm M; El-Halabi M; Allegretti JR; Kassam Z; Xu H; Fischer M Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2234-2243.e1. PubMed ID: 31923639 [TBL] [Abstract][Full Text] [Related]
24. Validation of the SHEA/IDSA severity criteria to predict poor outcomes among inpatients and outpatients with Stevens VW; Shoemaker HE; Jones MM; Jones BE; Nelson RE; Khader K; Samore MH; Rubin MA Infect Control Hosp Epidemiol; 2020 May; 41(5):510-516. PubMed ID: 31996280 [TBL] [Abstract][Full Text] [Related]
25. Predictors of Clostridioides difficile Infection-Related Complications and Treatment Patterns among Nucleic Acid Amplification Test-Positive/Toxin Enzyme Immunoassay-Negative Patients. Miller R; Morillas JA; Brizendine KD; Fraser TG J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31896665 [TBL] [Abstract][Full Text] [Related]
26. Predictors of Clostridioides difficile Infection Among Asymptomatic, Colonized Patients: A Retrospective Cohort Study. Poirier D; Gervais P; Fuchs M; Roussy JF; Paquet-Bolduc B; Trottier S; Longtin J; Loo VG; Longtin Y Clin Infect Dis; 2020 May; 70(10):2103-2210. PubMed ID: 31290544 [TBL] [Abstract][Full Text] [Related]
27. Changes in the Association Between Diagnostic Testing Method, Polymerase Chain Reaction Ribotype, and Clinical Outcomes From Clostridioides difficile Infection: One Institution's Experience. Menon A; Perry DA; Motyka J; Weiner S; Standke A; Penkevich A; Keidan M; Young VB; Rao K Clin Infect Dis; 2021 Nov; 73(9):e2883-e2889. PubMed ID: 32930705 [TBL] [Abstract][Full Text] [Related]
28. Assessing risk factors, mortality, and healthcare utilization associated with Clostridioides difficile infection in four Latin American countries. Yu H; Flaster N; Casanello AL; Curcio D Braz J Infect Dis; 2021; 25(1):101040. PubMed ID: 33290727 [TBL] [Abstract][Full Text] [Related]
29. Community-Associated Clostridioides difficile Infection in Children: A Review of Recent Literature. Adams DJ; Barone JB; Nylund CM J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S22-S26. PubMed ID: 34791398 [TBL] [Abstract][Full Text] [Related]
30. Retrospective study of the efficacy and safety of metronidazole and vancomycin for Clostridioides difficile infection. Misawa K; Iketani O; Enoki Y; Taguchi K; Uno S; Uwamino Y; Hasegawa N; Matsumoto K J Infect Chemother; 2021 Oct; 27(10):1407-1412. PubMed ID: 34023223 [TBL] [Abstract][Full Text] [Related]
31. Surgical Infection Society Guidelines for Total Abdominal Colectomy versus Diverting Loop Ileostomy with Antegrade Intra-Colonic Lavage for the Surgical Management of Severe or Fulminant, Non-Perforated Forrester JD; Colling KP; Diaz JJ; Faliks B; Kim PK; Tessier JM; Tung J; Huston JM Surg Infect (Larchmt); 2022 Mar; 23(2):97-104. PubMed ID: 34619068 [No Abstract] [Full Text] [Related]
32. Ultrasensitive and Quantitative Toxin Measurement Correlates With Baseline Severity, Severe Outcomes, and Recurrence Among Hospitalized Patients With Clostridioides difficile Infection. Alonso CD; Kelly CP; Garey KW; Gonzales-Luna AJ; Williams D; Daugherty K; Cuddemi C; Villafuerte-Gálvez J; White NC; Chen X; Xu H; Sprague R; Barrett C; Miller M; Foussadier A; Lantz A; Banz A; Pollock NR Clin Infect Dis; 2022 Jul; 74(12):2142-2149. PubMed ID: 34537841 [TBL] [Abstract][Full Text] [Related]
33. [Clostridioides difficile toxin B gen amplification cycle threshold as a predictor of severity]. Sante L; Kohan R; Blanco-Hortas A; Díaz Z; Lecuona M Rev Chilena Infectol; 2022 Feb; 39(1):29-34. PubMed ID: 35735277 [TBL] [Abstract][Full Text] [Related]
34. Laxative Use Does Not Preclude Diagnosis or Reduce Disease Severity in Clostridiodes difficile Infection. White NC; Mendo-Lopez R; Papamichael K; Cuddemi CA; Barrett C; Daugherty K; Pollock N; Kelly CP; Alonso CD Clin Infect Dis; 2020 Sep; 71(6):1472-1478. PubMed ID: 31584632 [TBL] [Abstract][Full Text] [Related]
35. Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI. Finn E; Andersson FL; Madin-Warburton M BMC Infect Dis; 2021 May; 21(1):456. PubMed ID: 34016040 [TBL] [Abstract][Full Text] [Related]
36. Predictors of Clostridium difficile infection severity in patients hospitalised in medical intensive care. Khanafer N; Touré A; Chambrier C; Cour M; Reverdy ME; Argaud L; Vanhems P World J Gastroenterol; 2013 Nov; 19(44):8034-41. PubMed ID: 24307797 [TBL] [Abstract][Full Text] [Related]
37. Severe Clostridium difficile infection: incidence and risk factors at a tertiary care university hospital in Vienna, Austria. Starzengruber P; Segagni Lusignani L; Wrba T; Mitteregger D; Indra A; Graninger W; Presterl E; Diab-Elschahawi M Wien Klin Wochenschr; 2014 Jul; 126(13-14):427-30. PubMed ID: 24903143 [TBL] [Abstract][Full Text] [Related]
38. Using diagnostic stewardship to reduce rates, healthcare expenditures and accurately identify cases of hospital-onset Solanky D; Juang DK; Johns ST; Drobish IC; Mehta SR; Kumaraswamy M Infect Control Hosp Epidemiol; 2021 Jan; 42(1):51-56. PubMed ID: 32943129 [TBL] [Abstract][Full Text] [Related]
39. Factors Associated with Clostridioides (Clostridium) Difficile Infection and Colonization: Ongoing Prospective Cohort Study in a French University Hospital. Khanafer N; Vanhems P; Bennia S; Martin-Gaujard G; Juillard L; Rimmelé T; Argaud L; Martin O; Huriaux L; Marcotte G; Hernu R; Floccard B; Cassier P; Group S Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299978 [No Abstract] [Full Text] [Related]
40. Clinical management of severe, fulminant, and refractory Cheng YW; Fischer M Expert Rev Anti Infect Ther; 2020 Apr; 18(4):323-333. PubMed ID: 32057278 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]